机构:[a]Division of Cellular and Molecular Research, National Cancer Centre Singapore[b]Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China临床科室肝胆胰科中山大学肿瘤防治中心[c]Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-Sen University[d]Department of Hepato-Pancreato-Biliary Surgery, Singapore General Hospital, Singapore[e]Department of Hepato-Pancreato-Biliary Surgery, Singapore General Hospital, Singapore; Division of Surgical Oncology, National Cancer Centre Singapore[f]Division of Cellular and Molecular Research, National Cancer Centre Singapore; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore; Institute of Molecular and Cell Biology, A*STAR, Singapore; Duke-NUS Medical School, Singapore
Wang Y,Gao B,Tan P.Y,et al.A genome-wide CRISPR cell growth screen identifies NCAPG as a new therapeutic target for hepatocellular carcinoma[J].ANNALS OF ONCOLOGY.2017,28:doi:10.1093/annonc/mdx511.002.
APA:
Wang, Y,Gao, B,Tan, P.Y,Handoko, Y.A,Sekar, K...&Hui, K.M.(2017).A genome-wide CRISPR cell growth screen identifies NCAPG as a new therapeutic target for hepatocellular carcinoma.ANNALS OF ONCOLOGY,28,
MLA:
Wang, Y,et al."A genome-wide CRISPR cell growth screen identifies NCAPG as a new therapeutic target for hepatocellular carcinoma".ANNALS OF ONCOLOGY 28.(2017)